๎
๎ผ
๎
Boston Scientific Corp
BSX101.360USD
+3.320+3.39%
์ข
๊ฐย 11/25, 16:00๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
150.24B์๊ฐ์ด์ก
53.83P/E TTM
๎
์์ธํ ๋ด์ฉ์ Boston Scientific Corp ํ์ฌ
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.
Boston Scientific Corp ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ BSX
ํ์ฌ ์ด๋ฆBoston Scientific Corp
์์ฅ์ผMay 19, 1992
CEOMr. Michael F. (Mike) Mahoney
์ง์ ์53000
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃMay 19
์ฃผ์300 Boston Scientific Way
๋์MARLBOROUGH
์ฆ๊ถ ๊ฑฐ๋์NYSE Consolidated
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ01752-1234
์ ํ15086834000
์น์ฌ์ดํธhttps://www.bostonscientific.com/en-US/Home.html
์ข
๋ชฉ ์ฝ๋ BSX
์์ฅ์ผMay 19, 1992
CEOMr. Michael F. (Mike) Mahoney
Boston Scientific Corp์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-3.25%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
+5.27%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.29K
+1.62%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+6.64%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
24.13K
-34.82%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
+58.67%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
-58.23%
Mr. Arthur Crosswell Butcher
Mr. Arthur Crosswell Butcher
Executive Vice President, Group President, MedSurg and Asia Pacific
Executive Vice President, Group President, MedSurg and Asia Pacific
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
๋ ๋ณด๊ธฐ
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-3.25%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
+5.27%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.29K
+1.62%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+6.64%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
24.13K
-34.82%
์์ต ๋ถ์
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Oct 6
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
์ฌ์
๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
Electrophysiology
840.00M
16.60%
Endoscopy
737.00M
14.56%
Interventional Cardiology Therapies
731.00M
14.44%
Peripheral Interventions
698.00M
13.79%
Urology
676.00M
13.36%
๊ธฐํ
1.38B
27.25%
์ง์ญ๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
United States
3.22B
63.70%
EMEA (Europe, Middle East and Africa)
878.00M
17.35%
Asia Pacific
790.00M
15.61%
Latin America and Canada
169.00M
3.34%
์ฌ์
๋ณ
์ง์ญ๋ณ
์ฌ์
๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
Electrophysiology
840.00M
16.60%
Endoscopy
737.00M
14.56%
Interventional Cardiology Therapies
731.00M
14.44%
Peripheral Interventions
698.00M
13.79%
Urology
676.00M
13.36%
๊ธฐํ
1.38B
27.25%
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Nov 8
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Nov 8
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
The Vanguard Group, Inc.
9.28%
Fidelity Management & Research Company LLC
6.11%
BlackRock Institutional Trust Company, N.A.
5.37%
State Street Investment Management (US)
4.38%
PRIMECAP Management Company
2.23%
๊ธฐํ
72.63%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
The Vanguard Group, Inc.
9.28%
Fidelity Management & Research Company LLC
6.11%
BlackRock Institutional Trust Company, N.A.
5.37%
State Street Investment Management (US)
4.38%
PRIMECAP Management Company
2.23%
๊ธฐํ
72.63%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Investment Advisor
50.76%
Investment Advisor/Hedge Fund
29.06%
Hedge Fund
4.91%
Pension Fund
2.94%
Research Firm
2.73%
Bank and Trust
1.88%
Sovereign Wealth Fund
1.58%
Family Office
0.23%
Private Equity
0.18%
๊ธฐํ
5.73%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Oct 1
๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Oct 1
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2025Q3
2840
1.40B
94.18%
+558.00K
2025Q2
2752
1.39B
93.57%
+165.36K
2025Q1
2744
1.39B
93.81%
-5.31M
2024Q4
2559
1.38B
93.61%
+1.09M
2024Q3
2417
1.37B
92.76%
-24.32M
2024Q2
2341
1.37B
93.29%
-18.17M
2024Q1
2227
1.37B
93.23%
-40.14M
2023Q4
2171
1.39B
94.95%
-25.34M
2023Q3
2110
1.39B
95.17%
-6.29M
2023Q2
2081
1.38B
95.67%
-15.63M
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
The Vanguard Group, Inc.
136.47M
9.21%
+2.53M
+1.89%
Jun 30, 2025
Fidelity Management & Research Company LLC
99.47M
6.71%
-17.98M
-15.31%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
78.19M
5.28%
+380.40K
+0.49%
Jun 30, 2025
State Street Investment Management (US)
65.19M
4.4%
+713.38K
+1.11%
Jun 30, 2025
PRIMECAP Management Company
34.66M
2.34%
-1.83M
-5.03%
Jun 30, 2025
Geode Capital Management, L.L.C.
32.42M
2.19%
+622.60K
+1.96%
Jun 30, 2025
Capital World Investors
28.52M
1.93%
-33.95K
-0.12%
Jun 30, 2025
Managed Account Advisors LLC
22.05M
1.49%
+765.61K
+3.60%
Jun 30, 2025
The Bollard Group, LLC
20.08M
1.36%
-411.38K
-2.01%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
19.46M
1.31%
-275.11K
-1.39%
Jun 30, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Nov 6
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Nov 6
์ด๋ฆ
๋น์จ
iShares U.S. Medical Devices ETF
11.98%
Goldman Sachs Future Health Care Equity ETF
7.69%
Invesco Dorsey Wright Healthcare Momentum ETF
4.06%
JPMorgan Healthcare Leaders ETF
3.67%
Tema Heart & Health ETF
3.64%
Segall Bryant & Hamill Select Equity ETF
3.46%
Parnassus Core Select ETF
2.95%
Health Care Select Sector SPDR Fund
2.87%
Proshares Ultra Health Care
2.86%
Knowledge Leaders Developed World ETF
2.85%
๋ ๋ณด๊ธฐ
iShares U.S. Medical Devices ETF
๋น์จ11.98%
Goldman Sachs Future Health Care Equity ETF
๋น์จ7.69%
Invesco Dorsey Wright Healthcare Momentum ETF
๋น์จ4.06%
JPMorgan Healthcare Leaders ETF
๋น์จ3.67%
Tema Heart & Health ETF
๋น์จ3.64%
Segall Bryant & Hamill Select Equity ETF
๋น์จ3.46%
Parnassus Core Select ETF
๋น์จ2.95%
Health Care Select Sector SPDR Fund
๋น์จ2.87%
Proshares Ultra Health Care
๋น์จ2.86%
Knowledge Leaders Developed World ETF
๋น์จ2.85%
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
๋ ์ง
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
์์ฃผ ๋ฌป๋ ์ง๋ฌธ
Boston Scientific Corp์ ์์ 5๋ ์ฃผ์ฃผ๋ ๋๊ตฌ์ธ๊ฐ์?
๎Boston Scientific Corp์ ์์ 5๋ ์ฃผ์ฃผ๋ ๋ค์๊ณผ ๊ฐ์ต๋๋ค:
The Vanguard Group, Inc.๋ 136.47M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 9.21%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Fidelity Management & Research Company LLC๋ 99.47M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 6.71%๋ฅผ ์ฐจ์งํฉ๋๋ค.
BlackRock Institutional Trust Company, N.A.๋ 78.19M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 5.28%๋ฅผ ์ฐจ์งํฉ๋๋ค.
State Street Investment Management (US)๋ 65.19M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 4.40%๋ฅผ ์ฐจ์งํฉ๋๋ค.
PRIMECAP Management Company๋ 34.66M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 2.34%๋ฅผ ์ฐจ์งํฉ๋๋ค.
The Vanguard Group, Inc.๋ 136.47M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 9.21%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Fidelity Management & Research Company LLC๋ 99.47M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 6.71%๋ฅผ ์ฐจ์งํฉ๋๋ค.
BlackRock Institutional Trust Company, N.A.๋ 78.19M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 5.28%๋ฅผ ์ฐจ์งํฉ๋๋ค.
State Street Investment Management (US)๋ 65.19M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 4.40%๋ฅผ ์ฐจ์งํฉ๋๋ค.
PRIMECAP Management Company๋ 34.66M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 2.34%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Boston Scientific Corp์ ์์ 3๋ ์ฃผ์ฃผ ์ ํ์ ๋ฌด์์ธ๊ฐ์?
๎Boston Scientific Corp์ ์ฃผ์ ์ฃผ์ฃผ ์ ํ ์์ 3๊ฐ์ง๋
The Vanguard Group, Inc.
Fidelity Management & Research Company LLC
BlackRock Institutional Trust Company, N.A.์ ๋๋ค.
The Vanguard Group, Inc.
Fidelity Management & Research Company LLC
BlackRock Institutional Trust Company, N.A.์ ๋๋ค.
Boston Scientific Corp(BSX)์ ์ฃผ์์ ๋ณด์ ํ ๊ธฐ๊ด์ ๋ช ๊ฐ์ ๋๊น?
๎2025Q3 ๊ธฐ์ค์ผ๋ก, Boston Scientific Corp์ ์ฃผ์์ ๋ณด์ ํ ๊ธฐ๊ด์ ์ด 2840๊ณณ์ด๋ฉฐ, ์ด๋ค์ด ๋ณด์ ํ ์ฃผ์์ ์ด ๊ฐ์น๋ ์ฝ 1.40B๋ก ์ ์ฒด ๋ฐํ ์ฃผ์์ 94.18%๋ฅผ ์ฐจ์งํฉ๋๋ค. ์ด๋ 2025Q2 ๋๋น 0.61% ์ฆ๊ฐํ ์์น์
๋๋ค.
Boston Scientific Corp์ ์ต๋ ์์ต์์ ๋ฌด์์ธ๊ฐ์?
๎FY2025Q2 ๊ธฐ์ค, Boston Scientific Corp์ Electrophysiology ๋ถ๋ฌธ์ด ๊ฐ์ฅ ๋์ ๋งค์ถ์ ๊ธฐ๋กํ์ผ๋ฉฐ, ๊ธ์ก์ 840.00M๋ก ์ ์ฒด ๋งค์ถ์ 16.60%๋ฅผ ์ฐจ์งํ์ต๋๋ค.
